Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma

Surgery

Volumn 131, Issue 1, 2002, Pages S142-S147

  Tanaka, Shinji ^a   Sugimachi, Keishi ^a   Maehara, Shin Ichiro ^a   Harimoto, Norifumi ^a   Shirabe, Ken ^a   Wands, Jack R ^a   Sugimachi, Keizo ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; CELL ADHESION MOLECULE; SOMATOMEDIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ARTICLE; CELL SURVIVAL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOGENESIS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 0036165823     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.119495     Document Type: Article

References (54)

1. Hepatic oncogenesis, IVD. Tumors of the liver
2. The IGF-1 receptor in cell growth, transformation and apoptosis
3. Rat hepatocyte proliferation is stimulated by insulin-like peptides in defined medium
4. Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers
5. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with Grb2 and Syp signaling molecules
6. Insulin receptor substrate-1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor-beta 1 induced apoptosis
7. A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals
8. Induction of the growth inhibitor IGF-binding protein 3 by p53
9. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
10. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
11. The IRS-1 signaling system
12. Role of IRS-2 in insulin and cytokine signaling
13. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain
14. Interaction between the Grb10 SH2 domain and the insulin receptor carboxyl terminus
15. Protein modules and signaling networks
16. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma
17. In vivo mitogenic effects of human insulin receptor substrate-1 (hIRS-1) overexpression in hepatocytes
18. Ethanol inhibits hepatocytes proliferation through the IRS-1 signal transduction pathway in transgene mice
19. Transforming potential of the insulin receptor substrate 1
20. A carboxy-terminal truncated IRS-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype
21. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome
22. Phenocopies induced with antisense RNA identify the wingless gene
23. Differential transformation of mammary epithelial cells by Wnt genes
24. Transformation by Wnt family proteins correlates with regulation of beta-catenin
25. A new member of the frizzled family from Drosophila functions as a wingless receptor
26. Frzl is a secreted antagonist of Wnt signaling expressed in the Spemann organizer
27. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
28. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53
29. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins
30. LDL-receptor-related proteins in Wnt signal transduction
31. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin
32. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3
33. Stabilization of beta-catenin by genetic defects in melanoma cell lines
34. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas
35. Overexpression of Frat 1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression
36. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
37. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving Axin 3
38. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection
39. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity
40. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation
41. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
42. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta
43. Axin 1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of Axin 1
44. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3
45. Functional interaction of beta-catenin with the transcription factor LEF-1
46. Beta-catenin mutations are absent in hepatocellular carcinomas of SV40 Tantigen transgenic mice
47. Differential nuclear translocation and trans-activation potential of beta-catenin and plakoglobin
48. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin
49. Insulin and IGF-1 stimulate the beta-catenin pathway through two signaling cascades involving GSK-3beta inhibition and Ras activation
50. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene
51. The increasing incidence of hepatocellular carcinoma
52. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
53. A novel variant of human Grb7 is associated with invasive esophageal carcinoma
54. Immunological approach to hepatocellular carcinoma